No insider purchase over the last 90 days. The latest was filed 27 May 2026.
CY5 belongs to the Chemicals sector. Filings by its managers are published through ASX. In the past year (18 October 2025 to 18 October 2026), 5 filings came from 5 insiders.
On the market, 1 insider bought (1 purchase totalling €7,669) while 2 insiders sold (2 sales totalling €1.1M). The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 senior executive. The largest single trade was a sale of €1.1M by David Southam, published on 28 September 2026, equal to 0.82% of the market capitalisation.
With 5 filings in twelve months, the company is more active than the median of 3 filings across the 2,530 companies we follow on the same exchange. Looking back to 2026, when coverage begins, insiders filed 1 purchase and 2 sales.
The last purchase on record was published on 27 May 2026, which is 143 days ago. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Other companies in the same sector with recent insider buying flagged by our signals: Culp Inc. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
5 of 5 declarations
CY5 is a company specializing in the chemistry and materials sector. It is listed on the XASX market.
Purchases our model currently ranks for the recommendations list.
All recommendations